| Cost-effectiveness of alternative approaches to the management of chronic obstructive coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 19898279 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Chronic obstructive coronary artery disease (CAD) is a highly prevalent condition that results in premature mortality as well as substantial morbidity due to angina and reduced quality of life. Various treatment and revascularization strategies are available for managing this condition, including medical therapy, percutaneous coronary intervention, and coronary artery bypass grafting. These treatments are expensive and, given the high prevalence of chronic CAD, there is substantial cost involved in the management of this condition. Recent clinical trials comparing percutaneous coronary intervention with medical management and/or coronary artery bypass grafting, and their associated economic analyses, have generated new information regarding the relative value of these alternative treatment strategies. In this article, we review the basic concepts of cost-effectiveness analysis and the current evidence as it relates to the cost-effectiveness of percutaneous coronary intervention in the management of chronic obstructive coronary artery disease. |
| | |
Authors:
|
Amit P Amin; David J Cohen |
Related Documents
:
|
8605639 - Coronary artery disease following repair of tetralogy of fallot: implications and manag... 12844109 - External iliac artery endofibrosis: a new possible predisposing factor. 16132279 - Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial a... 17977779 - Disappearance of resting tremor after thalamic stroke involving the territory of the tu... 9689799 - Long-term treatment with cyclosporin a and coumarin in pulmonary thromboembolic behçet... 16581699 - Mid-term outcome after carotid artery stenting depends on presence of coronary artery d... 11565659 - Off-pump bypass grafting is safe in patients with left main coronary disease. 2971789 - Causes of false-negative auscultation of regurgitant lesions: a doppler echocardiograph... 15305559 - Orbital cavernous hemangioma associated with juxtapapillary exophytic retinal capillary... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Reviews in cardiovascular medicine Volume: 10 Suppl 2 ISSN: 1530-6550 ISO Abbreviation: Rev Cardiovasc Med Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-11-09 Completed Date: 2010-11-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960007 Medline TA: Rev Cardiovasc Med Country: United States |
Other Details:
|
Languages: eng Pagination: S3-13 Citation Subset: IM |
Affiliation:
|
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Balloon, Coronary
/
economics* Cardiovascular Agents / economics*, therapeutic use* Chronic Disease Coronary Artery Bypass / economics* Coronary Artery Disease / economics*, therapy* Cost-Benefit Analysis Drug Costs Evidence-Based Medicine Health Care Costs* Hospital Costs Humans Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of left main and multivessel disease in the drug-eluting stent era.
Next Document: Interpreting the results of the COURAGE trial: a non-interventionalist perspective.